Helen Sabzevari's Net Worth
$7.04 Million
Who is Helen Sabzevari?
Helen Sabzevari has an estimated net worth of $7.04 Million. This is based on reported shares across multiple companies, which include PRECIGEN, INC., and Kinnate Biopharma Inc..
SEC CIK
Helen Sabzevari's CIK is 0001724195
Past Insider Trading and Trends
2020 was Helen Sabzevari's most active year for acquiring shares with 11 total transactions. Helen Sabzevari's most active month to acquire stocks was the month of December. 2020 was Helen Sabzevari's most active year for disposing of shares, totalling 10 transactions. Helen Sabzevari's most active month to dispose stocks was the month of December. 2023 saw Helen Sabzevari paying a total of $39,999.75 for 3,866,459 shares, this is the most they've acquired in one year. In 2021 Helen Sabzevari cashed out on 984,037 shares for a total of $2,839,294.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PRECIGEN, INC. (PGEN) Snapshot price: $0.9622
President and CEOHelen Sabzevari owns 2,221,076 units of Common Stock which is worth $2,137,119.33. In the year 2023 Helen Sabzevari acquired a total of 3,662,857 shares in PRECIGEN, INC. at a cost of $39,999.75, Helen also disposed a total of 1,441,781 shares of PRECIGEN, INC. equalling to $4,946,595.41.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +42.38% | 661.07K |
$1.40 | -$574,499.80 | 2.22M |
Apr 5
| |||
Form 4
| +4.32% | 64.62K |
$1.53 | -$117,762.57 | 1.56M |
Aug 23 - Aug 25
| |||
Form 4
| +6.08% | 85.73K |
$1.66 | -$92,719.30 | 1.5M |
Aug 16 - Aug 18
| |||
Form 4
| +7.65% | 100.15K |
$1.44 | -$59,667.84 | 1.41M |
Aug 9 - Aug 11
| |||
Form 4
| +7.27% | 88.72K |
$1.10 | -$58,157.00 | 1.31M |
Aug 2 - Aug 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
| +30.20% | 283.17K |
—
|
—
| 1.22M |
Mar 24
| |||
Form 4
| +2.50% | 22.86K |
$1.75 | $39,999.75 | 937.61K |
Jan 27
| |||
Form 4
| +1.97% | 17.66K |
—
|
—
| 914.76K |
Jan 4
| |||
Form 4
| +22.19% | 162.94K |
$1.19 | -$210,927.67 | 897.09K |
Scheduled
|
May 12 - May 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +1.48% | 10.71K |
$3.59 | -$24,986.96 | 734.15K |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
| +0.82% | 5.92K |
$3.67 | -$14,122.54 | 723.44K |
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
| +1.77% | 12.47K |
$5.43 | -$68,047.09 | 717.53K |
Scheduled
|
Jul 17 - Jul 19
| ||
Form 4
| +7.61% | 49.84K |
$6.40 | -$303,571.20 | 705.06K |
Scheduled
|
May 12 - May 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
| +57.78% | 239.96K |
$8.92 | -$2,318,535.22 | 655.21K |
Scheduled
|
Jan 5 - Jan 6
| ||
Form 4
| +2.12% | 8.63K |
$10.56 | -$95,506.70 | 415.26K |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
| +1.12% | 4.49K |
$10.16 | -$53,634.64 | 406.63K |
Scheduled
|
Jan 2 - Jan 4
| ||
Form 4
| +3.28% | 12.78K |
$4.58 | -$55,967.60 | 402.14K |
Scheduled
|
Jul 17 - Jul 20
| ||
Form 4
| +264.26% | 282.47K |
$2.37 | -$515,800.02 | 389.37K |
Scheduled
|
May 14 - May 15
| ||
Form 4
| +9.07% | 8.89K |
$3.01 | -$16,414.85 | 106.89K |
Scheduled
|
Mar 31 - Apr 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
| +12.56% | 10.94K |
$5.83 | -$39,242.85 | 98K |
Scheduled
|
Jan 4 - Jan 6
| ||
Form 4
| +7.24% | 5.88K |
$5.77 | -$22,421.44 | 87.07K |
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
| +13.27% | 9.51K |
$5.60 | -$27,048.00 | 81.19K |
Scheduled
|
Dec 31 - Jan 2
| ||
Form 4
| +14.98% | 9.34K |
$5.50 | -$27,506.98 | 71.68K |
Scheduled
|
Sep 30 - Oct 1
| ||
Form 4
| +36.04% | 16.52K |
$7.47 | -$63,377.18 | 62.34K |
Scheduled
|
Jul 17 - Jul 18
| ||
Form 4
| +26.22% | 9.52K |
$7.76 | -$37,418.72 | 45.83K |
Scheduled
|
Jun 30 - Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +61.13% | 13.77K |
—
|
—
| 36.31K |
Jan 4
| |||
Form 4
| +35.75% | 5.93K |
$7.07 | -$27,094.16 | 22.53K |
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
|
∞
| 16.6K |
$14.54 | -$122,165.08 | 16.6K |
Scheduled
|
Jul 17 - Jul 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kinnate Biopharma Inc. (KNTE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||